Table 4.
Therapeutic protocols in 658 patients with brucellosis in Kohgilouyeh and Boyerahmad province, Southwest of Iran
| Therapeutic combinations | Percentage n=658 n (%) | Duration (weeks) |
|---|---|---|
| Doxycycline + rifampin | 183 (27.8) | 2-8 |
| Doxycycline + streptomycin | 84 (13.1) | 1-8 |
| Doxycycline + streptomycin + rifampin | 54 (8.2) | 2-8 |
| Gentamicin + cotrimoxazole | 49 (7.4) | 2-8 |
| Gentamicin | 32 (4.9) | 1-2 |
| Cotrimoxazole + rifampin | 28 (4.3) | 2-8 |
| Rifampin | 23 (3.5) | 2-8 |
| Doxycycline + gentamicin + rifampin | 21 (3.2) | 2-8 |
| Tetracycline + rifampin | 17 (2.6) | 2-8 |
| Gentamicin + rifampin | 16 (2.4) | 1-4 |
| Streptomycin | 12 (1.8) | 1-3 |
| Streptomycin + rifampin | 10 (1.5) | 3-8 |
| Others | 129 (19.3) | 1-8 |